The Global CRISPR market is expected to witness a boost of 32.04% CAGR over the forecast period of 2019-2027

Wednesday, December 12, 2018 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 11, 2018 /PRNewswire/ -- KEY FINDINGSThe Global CRISPR market is expected to witness a boost of 32.04%

CAGR over the forecast period of 2019-2027. Factors like increasing demand of the technology for drug discovery, late pregnancies leading to birth disorders and growing investments for path-breaking research technology are fueling the market growth.Read
the full report: MARKET INSIGHTSThe global CRISPR market is segmented on the basis of products, applications, end-users.The product segment includes plasmids and vectors, design tools, Cas9 nuclease and gRNA, and delivery systems.The application segment includes genetic engineering, genome editing, gRNA database/gene library, human stem cells, CRISPR plasmid, genetically modified organisms/crops and cell line engineering. The end-users for the CRISPR market include research foundation, academic institutes, pharma companies and biotech firms.REGIONAL INSIGHTSRegional segmentation of the market is done into Europe, Asia-Pacific, North America and rest of the world CRISPR markets.The Asia-Pacific market is expected to register the fastest growth over the forecast period.The region is driven by high population growth in emerging nations of India and China and a growing prevalence of genetic diseases there. The North American market, on the other hand, is predicted to account for the highest revenue share by the end of the forecast period, with the U.S being its major contributor. The presence of leading market companies and growing consumer awareness related to this technology is responsible for propelling this region ahead.COMPETITIVE INSIGHTSThermo Fisher Scientific, Editas Medicine, Crispr Therapeutics Ag, Sigma-Aldrich (Merck), Horizon Discovery Plc, Genscript, Lonza Group Ag, Sangamo Biosciences Inc,Integrated DNA Technologies (IDT), Origene Technologies Inc, New England Biolabs Inc, Transposagen Biopharmaceuticals Inc, Caribou Biosciences Inc, Precision Biosciences, Intellia Therapeutics Inc, Cellectis Bioresearch SAS and Novartis International Ag are few of the companies engaged in the global CRISPR marketCompanies mentioned1. ADDGENE2. APPLIED STEMCELL, INC.3. CARIBOU BIOSCIENCES INC.4. CELLECTIS BIORESEARCH SAS5. CRISPR THERAPEUTICS AG6. DIACARTA, INC.7. EDIGENE, INC.8. EDITAS MEDICINE9. GENECOPOEIA, INC.10. GENEDATA AG11. GENSCRIPT12. HORIZON DISCOVERY PLC13. INTEGRATED DNA TECHNOLOGIES14. INTELLIA THERAPEUTICS INC.15. LONZA GROUP AG16. NEW ENGLAND BIOLABS INC.17. NOVARTIS INTERNATIONAL AG18. ORIGENE TECHNOLOGIES INC.19. PRECISION BIOSCIENCES20. SANGAMO THERAPEUTICS21. SIGMA-ALDRICH (MERCK)22. THERMO FISHER SCIENTIFIC23. TRANSPOSAGEN BIOPHARMACEUTICALS INC.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store